Inside The Tiny Italian Biotech Startup Racing To Develop A Coronavirus Vaccine

Apr 24, 2020 383

BY: Giacomo Tognini

Four days before the first cases of COVID-19 were confirmed in Italy on January 31, a small biotech firm in the outskirts of Rome announced it was pivoting its business. Researchers at Takis Biotech, which had been focused on cancer treatments, would instead set about developing a vaccine for the rapidly spreading coronavirus.

With the virus now ravaging almost every country on the planet, Takis, led by CEO and Chief Scientific Officer Luigi Aurisicchio, is aiming for human trials of its DNA-based vaccine in the fall.

Read more


You may be interested